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Solar ultraviolet irradiation damages human skin and
causes premature skin aging and skin cancer. As
transforming growth factor b plays an important role
in regulating cell growth and extracellular matrix
synthesis, we investigated expression of transforming
growth factor b isoforms, transforming growth
factor b receptors, and transforming growth factor b
regulated Smad transcription factors following
irradiation with an ultraviolet B source and solar-
simulated ultraviolet irradiation of human skin
in vivo. Full-thickness, sun-protected adult human
skin expressed transforming growth factor b1, b2,
and b3 transcripts in a ratio of 1:5:3, as determined
by quantitative real-time reverse transcription poly-
merase chain reaction. Northern analysis demon-
strated that the ultraviolet irradiation (2 minimal
erythema dose) caused moderate (2±3-fold) gradual
increases of transforming growth factor b1 and b3
mRNA expression during 3 d post exposure. In con-
trast, expression of transforming growth factor b2
mRNA, the predominant form of transforming
growth factor b in human skin, decreased within 4 h
after ultraviolet irradiation. In situ hybridization
revealed transforming growth factor b1, b2, and b3
mRNA expression in cells throughout the epidermis
and the dermis in nonirradiated skin. Following
ultraviolet or solar-simulated ultraviolet irradiation,
transforming growth factor b1 and b3 mRNA were
increased and transforming growth factor b2 mRNA
was reduced throughout the epidermis and dermis.
No signi®cant changes were observed in trans-
forming growth factor b type I receptor mRNA
expression after ultraviolet irradiation. In contrast,
transforming growth factor b type II receptor
mRNA expression was reduced 60% within 4 h
following ultraviolet exposure in human skin in vivo.
Transforming growth factor b type II receptor
mRNA levels remained reduced for 8 h and re-
covered by 24 h post ultraviolet. In situ hybridization
revealed that ultraviolet or solar-simulated ultraviolet
irradiation caused loss of transforming growth factor
b type II receptor mRNA in basal and suprabasal
cells in the epidermis and dermal cells. In addition,
no signi®cant changes were observed in Smad2,
Smad3, and Smad4 expression after ultraviolet irradi-
ation. In contrast, ultraviolet and solar-simulated
ultraviolet irradiation rapidly induced gene expres-
sion of Smad7, which antagonizes the actions of the
transforming growth factor b/Smad pathway. Smad7
mRNA induction occurred throughout the epidermis
and dermal cells as determined by in situ hybridiz-
ation. Ultraviolet irradiation also caused reduced
DNA binding of Smad3/4 in human skin in vivo.
Reduced Smad3/4 DNA binding was observed
within 4 h following irradiation. Taken together,
these results demonstrate that ultraviolet and solar-
simulated ultraviolet irradiation alter the transform-
ing growth factor b/Smad pathway in human skin
in vivo. Ultraviolet induction of Smad7 and reduction
of transforming growth factor b2 and transforming
growth factor b type II receptor should diminish
transforming growth factor b signaling, and probably
contribute to the decrease of transforming growth
factor b regulated type I and type III procollagen
gene expression observed in ultraviolet and solar-
simulated ultraviolet irradiated human skin in vivo.
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T
ransforming growth factor b (TGF-b) is a multi-
functional cytokine that plays an important role in
regulating cell growth, differentiation, and bio-
synthesis of extracellular connective tissue (Massague,
1998; Piek et al, 1999). TGF-b exists in a number of
structurally related 25 kDa homodimeric isoforms. In mammals,
TGF-b1, TGF-b2, and TGF-b3 isoforms have been identi®ed
(Jakowlew et al, 1988; ten Dijke et al, 1988). The TGF-bs initiate
their cellular action by binding to the cell surface receptors, TGF-b
type I receptor (TbRI) and TGF-b type II receptor (TbRII). Upon
ligand binding, the activated TGF-b receptor complex transiently
interacts with intracellular signal transducer, the receptor-regulated
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Smad proteins, which propagate TGF-b signals. The actions of the
TGF-bs are antagonized by Smad7, which interacts with TbRI to
prevent activation of the receptor-regulated Smads, thereby
blocking TGF-b signaling (Topper et al, 1997; Ulloa et al, 1999).
TGF-b is a potent growth inhibitor of human skin keratinocytes
(Rizzino, 1988). A wealth of evidence suggests that the TGF-b/
Smad pathway plays an important role in cancer development (Cui
et al, 1996; Portella et al, 1998). TGF-b/Smad signaling acts as a
tumor suppressor pathway by virtue of its role in inhibiting
epithelial cell proliferation. Many human cancer cells, including
human skin cancer, become insensitive to the growth inhibitory
effects of the TGF-b/Smad pathway as a result of inactivating
mutations or deletions in TGF-b signaling components such as
TbRII, Smad2, or Smad4 (Markowitz et al, 1995; Riggins et al,
1997; Kretzschmar, 2000; Markowitz, 2000). TGF-b is also the
major regulator of extracellular matrix synthesis in human skin
(Roberts et al, 1992; Chen et al, 2000; Mori et al, 2000). TGF-b
stimulates ®broblast proliferation in the dermis to enhance collagen
synthesis (Penttinen et al, 1988; Inagaki et al, 1994; Jimenez et al,
1994; Chung et al, 1996). In addition, TGF-b upregulates
plasminogen activation inhibitor 1 and tissue inhibitor metallo-
proteinase, two major inhibitors of extracellular-matrix-degrading
enzymes. TGF-b can also downregulate expression of proteolytic
enzymes such as collagenase and stromelysin, which degrade
extracellular matrix proteins (Massague, 1990).
Ultraviolet (UV) irradiation damages human skin and causes
premature skin aging and skin cancer. A large body of evidence
indicates that UV irradiation is the major etiologic agent of human
skin cancer as a tumor initiator and promoter (Hata, 2001; Wang,
2001; Wieser, 2001; Wong and Lai, 2001). It is well established that
UV irradiation induces DNA damage and mutations that play an
essential role in skin cancer induction. In addition, UV irradiation
induces many changes in gene expression and signaling pathways.
For example, UV activates many cell surface cytokines and growth
factor receptors and rapidly induces c-Jun expression through
activation of mitogen-activated protein kinase pathways (Fisher et al,
1996; 1997; 1999; Fisher and Voorhees, 1998). Elevated c-Jun
plays an important role in UV-induced skin photoaging either by
inducing collagen-degrading matrix metalloproteinase or by
inhibiting type I procollagen synthesis (Fisher et al, 2000). Recent
evidence indicates that c-Jun functionally associates with Smad
protein to either inhibit or stimulate TGF-b-induced cellular
response (Rossert and Garrett, 1995; Verrecchia et al, 2000). Thus
it is likely that UV irradiation can exert some in¯uence on the
TGF-b/Smad pathway. Despite the important role of the TGF-b/
Smad pathway in cell growth and extracellular matrix regulation,
there has been no systematic investigation of how UV irradiation
affects the TGF-b/Smad signaling pathway in human skin in vivo.
Therefore, we have investigated the expression of TGF-b ligands,
TGF-b receptors, and Smad in human skin in vivo following UV
irradiation. Our results indicate that UV irradiation alters the TGF-
b/Smad pathway in human skin in vivo and that these alterations
may contribute to UV-induced human skin photoaging and skin
cancer.
MATERIALS AND METHODS
Procurement of human tissue samples and UV irradiation
procedures Human skin keratome and punch biopsies were obtained
from healthy adult human volunteers, as previously described (Fisher et
al, 1997; 1998). Sun-protected buttock skin of human volunteers was
irradiated with 2 minimal erythema dose (MED) with a UVB source
using an Ultralite Panelite lamp containing six FS36T12 UVB-HO bulbs
(54% UVB, 31% UVA2, 15% UVA1, ®ltered with kodcel to remove
wavelengths below 290 nm) or solar-simulated UV (SPEC solar 450 W
xenon arc simulator, UVB 6.9%, UVA2 15.9%, UVA1 77.2%). Biopsies
were taken at the indicated time points after UV exposure. All
procedures involving human subjects were approved by the University of
Michigan Institutional Review Board, and all subjects provided written
informed consent.
RNA isolation and northern analysis Frozen skin samples were
ground into ®ne powder in liquid nitrogen and homogenized by
polytron. Total RNA was puri®ed by cesium chloride density
centrifugation as previously described (Fisher et al, 1995). Northern
analysis was performed as described previously (Quan et al, 2001).
Brie¯y, total RNA (30 mg) was resolved by 1.2% agarose electrophoresis,
transferred to nylon membranes, and hybridized with TGF-b1, TGF-b2,
TGF-b3, TbRI, TbRII, and Smad7 cDNA probes labeled with
[32P]dCTP by random priming. cDNA probes for TGF-b1 (Derynck
et al., 1985) and Smad7 (Nakao et al, 1997) were generously provided by
Drs Rik Derynck and Peter ten Dijke, respectively. cDNA probes for
TGF-b2, TGF-b3, TbRI, TbRII were generated by reverse transcrip-
tion polymerase chain reaction (RT-PCR) from human skin RNA using
the following primers: for TGF-b2, 5¢-AATGTGCAGGATAAT-
TGCTGC-3¢ and 5¢-AGAAAGCTGTTCAATCTTGGG-3¢; for TGF-
b3, 5¢-GGTCCTGGCCCTGCTGAACTTTG-3¢ and TGTCTGCAC-
TGCGGAGGTATGG; for TbRI, 5¢-CCTGGCCTTGGTCCTGTG-3¢
and 5¢-TCTGTGGCTGAATCATGTCTTACT-3¢; for TbRII, 5¢-
AACTGTGTAAATTTTGTGATGTGA-3¢ and 5¢-CGGGCCTCT-
GGGTCGTG-3¢. PCR products were subcloned into the pCRII vector
(Invitrogen, Carlsbad, CA) and veri®ed by restriction digestion and
sequencing. Each blot was stripped and rehybridized with 36B4 cDNA
probes as internal control to monitor the sample load in each lane. The
intensities of each band were quanti®ed by STORM PhosphorImager
(Molecular Dynamics, Sunnyvale, CA) and normalized to the 36B4
transcript (Fisher et al, 1991).
Quantitative real-time RT-PCR Total RNA was extracted using a
commercial kit (RNeasy Mini kit, Qiagen, Chatsworth, CA) and reverse
transcription was performed using Taqman Reverse Transcription kit
(Applied Biosystems, Foster City, CA). Real-time PCR was performed
using a Taqman Universal PCR Master Mix kit (Applied Biosystems)
and 7700 Sequence Detector (Applied Biosystems). PCR primers and
probes were produced by the custom oligonucleotide synthesis service
(Applied Biosystems). The primers and FAM-labeled probes for TGF-b1,
TGF-b2, and TGF-b3 are as follows: TGF-b1 primers, 5¢-TGACAA-
GTTCAAGCAGAGTACACACA-3¢ and 5¢-AGAGCAACACGGGTT-
CAGGTA-3¢; TGF-b1 probe, 5¢-TCAACACATCAGAGCTCCGAG-
AAGCG-3¢; TGF-b2 primers, 5¢-AATTATCCTGCACATTTCTAA-
AGCAA-3¢ and 5¢-GACCAACCGGCGGAAGA-3¢, TGF-b2 probe, 5¢-
AGGCCGCATCCAAAGCACGC-3¢; TGF-b3 primers, 5¢-ATCACC-
ACAACCCTCATCTAATCCT-3¢ and 5¢-CCTGGCCCGGGTTGTC-
3¢, TGF-b3 probe, 5¢-ATGATGATTCCCCCACACCGGCT-3¢. The
primers and VIC-labeled probe for 36B4 are as follows: 5¢-ATG-
CAGCAGATCCGCATGT-3¢ and 5¢-TTGCGCATCATGGTGTT-
CTT-3¢; probe, 5¢-CGCGGGAAGGCTGTGGTGCT-3¢. Target gene
mRNA levels (number of molecules per 10 ng total RNA) were
quanti®ed based on standard and normalized to 36B4 mRNA levels.
In situ hybridization pCRII (Invitrogen) plasmids containing human
TGF-b1, TGF-b2, TGF-b3, TbRII, and Smad7 were linearized with
NotI and BamHI for sense and antisense probes, respectively.
Digoxigenin-containing sense and antisense riboprobes were synthesized
using SP6 and T7 ribonucleic polymerase. Frozen skin sections (5 mm)
were mounted, ®xed, treated, and hybridized as previously described
(Fisher et al, 1997). The hybridization signals were detected immuno-
histochemically by alkaline-phosphatase-conjugated antidigoxigenin
antibody.
Immunohistology Skin cryosections were air dried and ®xed in
paraformaldehyde for 20 min. Sections were preincubated with normal
goat serum (1/10) for 1 h. Subsequently, the slides were incubated for 1
h at room temperature with rabbit polyclonal antibodies against TGF-b1
(sc-146, Santa Cruz Biotechnology, 1:800), TGF-b2 (sc-90, Santa Cruz
Biotechnology, 1:100), and TGF-b3 (sc-82, Santa Cruz Biotechnology,
1:100). To verify antibody speci®city, antibodies were incubated with
antigenic peptides (Santa Cruz Biotechnology) for 30 min prior to
addition to skin sections. Sections were then incubated with a
biotinylated goat antirabbit antibody (1/200) for 30 min. Sections were
then incubated with avidin biotin peroxidase complex (1/500) for
30 min. 3-Amino-9-ethyl carbazole (Sigma Chemical, St. Louis, MO)
was used as chromogen. Between steps, the slides were rinsed for 10 min
in Tris-buffered saline with 0.1% Triton X-100. All sections were lightly
counterstained with hematoxylin.
Electrophoretic mobility shift assay (EMSA) Gel mobility shift
assays were performed using whole cell extracts from human skin
samples. Double-stranded oligodeoxynucleotides containing the CAGA
Smad binding element 5¢-TCGAGAGCCAGACAAGGAGCCAGA-
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CAAGGAGCCAGACAC-3¢ and its complementary strand were used as
probe (Quan et al, 2001). All oligonucleotides were synthesized by
Operon Technologies (Alameda, CA). EMSAs were performed as
described previously (Quan and Fisher, 1999; Quan et al, 2001).
Statistical analysis Comparisons among treatment groups were made
with the paired t test (two groups) or repeated measures of ANOVA
(more than two groups). Multiple pairwise comparisons were made with
the Tukey Studentized range test. All p-values are two-tailed, and
signi®cant when less than 0.05.
RESULTS
UV irradiation differentially alters gene expression of
TGF-b1, TGF-b2, and TGF-b3 in human skin in vivo To
investigate the effect of UV irradiation on TGF-b gene expression
in human skin in vivo, human skin biopsies were taken at 4, 8, 16,
24, 48, and 72 h following UV irradiation (2 MED, UVB source).
The mRNA levels of TGF-b1, TGF-b2, and TGF-b3 were
measured by northern analysis (Fig 1). Transcripts for all TGF-b
isoforms were detectable in nonirradiated human skin by northern
analysis although TGF-b1 and TGF-b3 mRNA levels were
consistently lower than TGF-b2 (Fig 1). Quantitation of the
number of transcripts for each of the three TGF-b isoforms by real-
time RT-PCR demonstrated that TGF-b2 transcripts were ®ve
times more abundant than TGF-b1 transcripts and 1.5 times more
abundant than TGF-b3 transcripts (n = 9, data not shown). UV
irradiation caused modest gradual increases in TGF-b1 and TGF-
b3 mRNA at 24, 48, and 72 h post UV. By 72 h post UV, both
TGF-b1 and TGF-b3 mRNA levels had increased approximately
2-fold. In contrast, TGF-b2 mRNA levels were sharply reduced
within 4 h post UV and remained reduced approximately 70% for
at least 72 h.
Localization of TGF-b1, TGF-b2, and TGF-b3 mRNA
expression following UV irradiation in human skin
in vivo In nonirradiated human skin, TGF-b1, TGF-b2, and
TGF-b3 mRNA were detectable in keratinocytes throughout the
epidermis and in dermal cells (Fig 2a, d, g). Changes in TGF-b1,
TGF-b2, and TGF-b3 mRNA following UV irradiation (2 MED)
with either a UVB source (Fig 2) or a solar simulator (Fig 3)
observed with in situ hybridization were similar to those observed
with northern analysis. At 72 h post UV irradiation TGF-b1 and
TGF-b3 mRNA were increased in keratinocytes throughout the
epidermis and dermis (Figs 2b, 2h, 3b, 3h). UV had no effect on
TGF-b1 and TGF-b3 transcripts at 4±16 h post UV (data not
shown). In contrast, TGF-b2 mRNA was reduced as early as 4 h
post UV (data not shown), and remained reduced by 72 h post UV
(Figs 2e, 3e). Hybridization of UV-irradiated skin with sense TGF-
b1, TGF-b2, and TGF-b3 probes yielded no detectable signals
(Figs 2c, 2f, 2i, and 3c, 3f, 3i), indicating that hybridization of the
antisense riboprobes was speci®c.
UV irradiation alters TGF-b1, TGF-b2, and TGF-b3 protein
expression in human skin in vivo We next determined the
Figure 2. Localization of TGF-b1, TGF-b2,
and TGF-b3 mRNA expression following
UV irradiation in human skin in vivo ± in situ
hybridization. Full-thickness 4 mm biopsies
were obtained 72 h post UV (2 MED) irradiation.
Cryostat sections were hybridized with TGF-b1,
TGF-b2, and TGF-b3 sense or antisense ribo-
probes, as described in Materials and Methods.
(a) TGF-b1 antisense probe for nonirradiated skin;
(b) TGF-b1 antisense probe for UV-irradiated
skin; (c) UV-irradiated skin with TGF-b1 sense
probe; (d) TGF-b2 antisense probe for non-
irradiated skin; (e) TGF-b2 antisense probe for
UV-irradiated skin; (f ) UV-irradiated skin with
TGF-b2 sense probe; (g) TGF-b3 antisense probe
for nonirradiated skin; (h) TGF-b3 antisense probe
for UV-irradiated skin; and (i) UV-irradiated skin
with TGF-b3 sense probe. Panels show results for
a single individual, but are representative of six
individuals.
Figure 1. UV irradiation alters TGF-b1, TGF-b2, and TGF-b3
mRNA expression in human skin in vivo ± northern analysis.
Human skin biopsies were obtained at the indicated times following
exposure to UVB (2 MED, UVB source). mRNAs for TGF-b1, TGF-
b2, and TGF-b3 were analyzed by northern analysis and quantitated by
STORM PhosphorImager. Data were normalized to mRNA for 36B4, a
ribosomal protein used as an internal control for quantitation. The insets
in each panel show representative northern blots. Bar heights represent
means 6 SEM. Data are expressed as fold change in mRNA levels
relative to levels in nonirradiated control skin. *p < 0.05 vs nonirradiated
control skin, n = 6±7.
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localization of TGF-b proteins in human skin in vivo by
immunohistology. Changes in TGF-b1, TGF-b2, and TGF-b3
protein levels in immunohistochemically stained sections of UV-
exposed human skin were essentially similar to the changes detected
in mRNA levels by in situ hybridization. In nonirradiated skin,
TGF-b1 protein was detectable at low levels throughout the
epidermis and the dermis (Fig 4a), TGF-b2 protein was strongly
stained throughout the epidermis and some dermal cells (Fig 4d),
whereas TGF-b3 protein was most prominent in the lower
epidermis (Fig 4g). At 72 h post UV, a signi®cant increase in TGF-
b1 staining was observed, which was primarily localized in the
dermis (Fig 4b). TGF-b3 staining, which primarily localized in the
epidermis, was also increased 72 h post UV irradiation (Fig 4h). In
contrast, TGF-b2 protein expression strongly decreased throughout
the epidermis following exposure to UV (Fig 4e). Preincubation of
TGF-b1, TGF-b2, and TGF-b3 antibodies with their cognate
antigenic peptides resulted in no detectable staining (Fig 4c, f, i).
UV irradiation reduces TbRII but not TbRI gene expression
in human skin in vivo We next examined the effect of UV
irradiation (UVB source) on TbRI and TbRII mRNA expression
by northern analysis. UV irradiation caused rapid and transient
inhibition of TbRII mRNA expression (Fig 5). TbRII mRNA
was reduced within 4 h post UV and remained reduced for at
least 8 h. At these time points, TbRII mRNA was reduced
approximately 60%, and returned to the initial level observed in
nonirradiated skin at 16±24 h post UV. In contrast, no signi®cant
changes were observed in TbRI mRNA expression up to 24 h post
UV irradiation.
Figure 4. UV irradiation alters TGF-b1,
TGF-b2, and TGF-b3 protein expression in
human skin in vivo ± immunohistology.
Biopsied skin samples were obtained 72 h after
exposure to UV (2 MED), and were localized by
immunohistology, as described in Materials and
Methods. (a) TGF-b1 nonirradiated skin; (b) TGF-
b1 UV-irradiated skin; (c) UV-irradiated skin with
TGF-b1 blocking peptide; (d) TGF-b2
nonirradiated skin; (e) TGF-b2 UV-irradiated
skin; (f ) UV-irradiated skin with TGF-b2
blocking peptide; (g) T GF-b3 nonirradiated skin;
(h) TGF-b3 UV-irradiated skin; (i ) UV-irradiated
skin with TGF-b3 blocking peptide. Panels show
results for a single individual, but are
representative of six individuals.
Figure 3. Localization of TGF-b1, TGF-b2,
and TGF-b3 mRNA expression following
solar-simulated UV irradiation in human
skin in vivo ± in situ hybridization. Full-
thickness 4 mm biopsies were obtained 72 h post
UV (2 MED, solar simulator) irradiation. Cryostat
sections were hybridized with TGF-b1, TGF-
b2, and TGF-b3 sense or antisense riboprobes,
as described in Materials and Methods. (a) TGF-b1
antisense probe for nonirradiated skin; (b) TGF-b1
antisense probe for UV-irradiated skin; (c) UV-
irradiated skin with TGF-b1 sense probe; (d) TGF-
b2 antisense probe for nonirradiated skin;
(e) TGF-b2 antisense probe for UV-irradiated
skin; (f ) UV-irradiated skin with TGF-b2 sense
probe; (g) TGF-b3 antisense probe for non-
irradiated skin; (h) TGF-b3 antisense probe for
UV-irradiated skin; and (i) UV-irradiated skin
with TGF-b3 sense probe. Panels show results for
a single individual, but are representative of six
individuals.
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Localization of TbRII mRNA expression following UV or
solar-simulated UV irradiation in human skin in vivo We
next utilized in situ hybridization to localize TbRII mRNA
expression in nonirradiated and either UV or solar simulator UV
irradiated human skin (2 MED). In nonirradiated skin, TbRII
mRNA was expressed in keratinocytes throughout the epidermis
and in some dermal cells (Figs 6a, 7a). Irradiation with either a
UVB source (Fig 6b) or UV solar simulator (Fig 7b) caused
reduction of TbRII mRNA expression within 8 h post exposure.
TbRII mRNA expression recovered to that observed in
nonirradiated skin within 24 h post UV (data not shown).
Hybridization of UV irradiated skin with TbRII cDNA sense
probes yielded no detectable signals (Figs 6c, 7c), indicating that
hybridization of the antisense probes was speci®c. Immuno-
histology revealed that UV-induced alterations of TbRII protein
expression paralleled those observed for mRNA levels (data not
shown).
UV irradiation induces Smad7 mRNA expression in human
skin in vivo TGF-b signaling is mediated by Smad2 and Smad3,
which in combination with Smad4 function as transcriptional
regulators. Activation of Smad2 and Smad3 is antagonized by
Smad7. We were unable to detect signi®cant changes in Smad2,
Smad3, and Smad4 protein expression in human skin following UV
irradiation (data not shown). In contrast, UV irradiation induced
Smad7 mRNA levels within 4 h post UV (Fig 8). Maximum
induction (2.5-fold) was observed at 8 h post UV. Smad7 mRNA
remained elevated for 16 h, and then decreased to below its initial
basal level observed in nonirradiated skin at 24±72 h post UV
(Fig 8).
Localization of Smad7 mRNA expression following UV or
solar-simulated UV irradiation in human skin in vivo Smad7
mRNA expression was localized in nonirradiated human skin and
irradiated skin with a UVB source or solar-simulated UV (2 MED)
by in situ hybridization. In nonirradiated skin, Smad7 mRNA was
expressed in keratinocytes throughout the epidermis and in some
Figure 5. UV irradiation inhibits TbRII mRNA but not TbRI
mRNA in human skin in vivo ± northern analysis. Human skin
biopsies were obtained at the indicated times following exposure to UV
(2 MED). mRNAs for TbRI and TbRII were analyzed by northern
analysis and quantitated by STORM PhosphorImager. Data were
normalized to mRNA for 36B4, a ribosomal protein used as an internal
control for quantitation. The insets show representative northern blots.
Bar heights represent means 6 SEM. Data are expressed as percentage of
change in mRNA levels relative to levels in nonirradiated control skin.
*p < 0.05 vs nonirradiated control skin, n = 6.
Figure 6. UV irradiation inhibits TbRII mRNA in human skin
in vivo ± in situ hybridization. Full-thickness 4 mm skin biopsies were
obtained from nonirradiated skin and 8 h following exposure to UV (2
MED, UVB source) irradiation. Cryostat sections (5 mm) were
hybridized with TbRII sense or antisense riboprobes, as described in
Materials and Methods. (a) TbRII antisense probe for nonirradiated skin;
(b) TbRII antisense probe for UV-irradiated skin; (c) UV-irradiated skin
with TbRII sense probe. Panels show results for a single individual, but
are representative of six individuals.
Figure 7. Solar-simulated UV irradiation inhibits TbRII mRNA
in human skin in vivo ± in situ hybridization. Full-thickness 4 mm
skin biopsies were obtained from nonirradiated skin and 8 h following
exposure to solar-simulated UV (2 MED) irradiation. Cryostat sections
(5 mm) were hybridized with TbRII sense or antisense riboprobes, as
described in Materials and Methods. (a) TbRII antisense probe for
nonirradiated skin; (b) TbRII antisense probe for UV-irradiated skin;
(c) UV-irradiated skin with TbRII sense probe. Panels show results for a
single individual, but are representative of six individuals.
Figure 8. UV irradiation induces Smad7 mRNA expression in
human skin in vivo ± northern analysis. Human skin biopsy
specimens were obtained at the indicated times following exposure to
UV (2 MED). mRNA for Smad7 was analyzed by northern analysis and
quantitated by STORM PhosphorImager. Data were normalized to
mRNA for 36B4, a ribosomal protein used as an internal control for
quantitation. The inset shows representative northern analysis at each
time point. Bar heights represent means 6 SEM. Data are expressed as
fold increase in mRNA levels relative to levels in nonirradiated control
skin. *p < 0.05 vs nonirradiated control skin, n = 6.
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dermal cells (Figs 9a, 10a). UV irradiation caused induction of
Smad7 mRNA at 4 and 8 h (Fig 9b, c), which was then followed
by a decrease to below basal levels 24 h post UV (Fig 9d). A similar
induction of Smad7 mRNA was observed 8 h post exposure to
solar-simulated UV (Fig 10b). Hybridization of UV or solar-
simulated UV irradiated skin with Smad7 cDNA sense probes
yielded no detectable signals (Figs 9e, 10c), indicating that
hybridization of the antisense probes was speci®c.
UV irradiation inhibits Smad/DNA complex formation in
human skin in vivo UV inhibition of TbRII and induction of
Smad7 are expected to reduce activation of Smad2 and Smad3 and
thereby reduce their nuclear translocation and binding to target
genes. To investigate this possibility, we performed EMSA, using
well-characterized Smad3/4 binding oligonucleotides as a probe
(Zawel et al, 1998; Quan et al, 2001). Human skin biopsies were
taken at 4, 8, 16, 24 h following UV irradiation (2 MED) and then
whole cell extracts were extracted for EMSA. As shown in Fig 11,
exposure of human skin to UV irradiation substantially reduced
formation of the retarded DNA/Smad complex. These data
demonstrate that UV irradiation inhibits DNA binding of Smad
proteins.
DISCUSSION
In this study, we have investigated the effect of UV irradiation on
expression of TGF-b isoforms, TGF-b receptors, and Smad genes
involved in TGF-b signaling (e.g., Smad2, Smad3, Smad4, and
Smad7) in human skin in vivo. In mammals, three isoforms, TGF-
b1, TGF-b2, TGF-b3, have been identi®ed; the amino acid
homology between isoforms ranges from 70% to 79% (ten Dijke
et al, 1988; Jakowlew et al, 1988) and they are nearly 100%
conserved across species. Despite high conservation between
TGF-b isoforms and similar functions in vitro, TGF-b isoforms
exert distinct biologic effects due to different expression patterns
and different effects on speci®c cell types in vivo. Gene knockout
mice missing each of the three TGF-b genes exhibit little or no
overlapping phenotype, suggesting that each isoform functions
differently (Shull et al, 1992; Kulkarni et al, 1993; Kaartinen et al,
1995; Proetzel et al, 1995; Sanford et al, 1997). Dermal thickness
was reduced in TGF-b2-de®cient mice, but not in TGF-b1- and
TGF-b3-de®cient mice (Foitzik et al, 1999). TGF-b2 null mice
exhibited a profound delay in hair follicle morphogenesis; however,
TGF-b1 and TGF-b3 null mice showed little or no effect on hair
development (Foitzik et al, 1999). It has also been shown that TGF-
b1, TGF-b2, and TGF-b3 are differentially expressed throughout
embryogenesis and carcinogenesis (Pelton et al, 1991; Gold et al,
2000). Sequence analysis has revealed that there is substantial
divergence between each TGF-b gene promoter, indicating that
each TGF-b gene may be regulated differently (Kim et al, 1989;
Figure 9. Localization of Smad7 mRNA expression following UV irradiation in human skin in vivo ± in situ hybridization. Full-thickness
4 mm skin biopsies were obtained following exposure to UV (2 MED). Cryostat sections (5 mm) were hybridized with Smad7 sense or antisense
riboprobes, as described in Materials and Methods. (a) Smad7 antisense probe for nonirradiated skin; (b) Smad7 antisense probe for UV-irradiated skin
(4 h); (c) Smad7 antisense probe for UV-irradiated skin (8 h); (d) Smad7 antisense probe for UV-irradiated skin (24 h); (e) UV-irradiated skin (8 h) with
Smad7 sense probe. Panels show results for a single individual, but are representative of six individuals.
Figure 10. Localization of Smad7 mRNA expression following
solar-simulated UV irradiation in human skin in vivo ± in situ
hybridization. Full-thickness 4 mm skin biopsies were obtained
following exposure to solar-simulated UV (2 MED). Cryostat sections
(5 mm) were hybridized with Smad7 sense or antisense riboprobes, as
described in Materials and Methods. (a) Smad7 antisense probe for
nonirradiated skin; (b) Smad7 antisense probe for UV-irradiated skin
(8 h); (c) UV-irradiated skin (8 h) with Smad7 sense probe. Panels show
results for a single individual, but are representative of six individuals.
Figure 11. UV irradiation inhibits Smad/DNA complex
formation in human skin in vivo ± EMSA. Sun-protected human
skin keratome biopsies were taken at 4, 8, 16, 24 h following UV
irradiation (2 MED) and then whole cell extracts were extracted.
Samples were analyzed by EMSA using well-characterized Smad3/4
binding oligonucleotides as a probe. Closed triangle indicates speci®c
retarded complexes. Open triangles indicate nonspeci®c bands (NS).
n = 3.
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O'Reilly et al, 1992; Gieser et al, 1993). Transcription of TGF-b1
and TGF-b3, but not TGF-b2, is regulated by SP1 and several
oncogens, including Jun and Fos (Kim, 1990). These observations
are consistent with our ®nding that each TGF-b isoform is
regulated differently by UV irradiation in human skin in vivo. We
found that UV irradiation rapidly decreases expression of TGF-b2
and increases expression of TGF-b1 and TGF-b3 at later times (48±
72 h). Based on in situ hybridization and immunohistology, the
basal level of TGF-b2 was strongly expressed throughout the
epidermis and dermis, but was quickly reduced following exposure
to UV. These data raise the possibility that TGF-b2 may play an
important role in UV-induced skin photoaging and tumorigenesis.
The speci®c biologic functions of each TGF-b isoform and their
role in photoaging and tumorigenesis in human skin remains to be
elucidated.
TGF-b initiates its signals through interactions with TGF-b
receptors. These transmembrane serine±threonine kinase receptors
exist as independent homodimers in the absence of TGF-b-ligand
binding. Binding of TGF-b to TbRII results in the formation of a
heteromeric complex between TbRI and TbRII, resulting in
phosphorylation of TbRI by TbRII. Binding of TGF-b to TbRII
is the ®rst critical step in the TGF-b signaling cascade because
TbRI does not bind TGF-b directly (Laiho et al, 1991; Wrana and
Attisano, 2000). Our data indicate that UV irradiation of human
skin targets this ®rst step by causing inhibition of TbRII mRNA
expression. TbRII mRNA was downregulated by UV as early as
4 h post UV and remained reduced for at least 8 h. In cultured
cells, we have found that UV downregulation of TbRII mRNA is
associated with reduced TbRII protein and TGF-b binding (Quan
et al, 2001). Decreased expression of TbRII mRNA following UV
irradiation would interfere with TGF-b responsiveness in human
skin. This possibility is consistent with our ®nding that UV
irradiation impairs Smad3/4 DNA binding (Quan et al, 2001). In
contrast to TbRII, no signi®cant changes were observed on TbRI
mRNA expression after UV irradiation. Future studies are needed
to clarify the mechanisms by which UV downregulates TbRII
expression.
The actions of the TGF-bs are antagonized by Smad7. Smad7
interacts with the activated TbRI to prevent activation of Smad2
and Smad3, thus interrupting ligand-induced signaling. Expression
of Smad7 is induced by TGF-b itself, suggesting that participation
in negative feedback loops regulates the intensity and duration of
the TGF-b response (Whitman, 1997). Induction of Smad7 gene
expression in human skin by UV was rapid and transient.
Interestingly, Smad7 mRNA was signi®cantly reduced at later
time points (24, 48, and 72 h).
Interestingly, our ®ndings are that irradiation with a UVB source
and solar-simulated UV elicit similar alterations in the TGF-b/
Smad pathway. We have found that several other responses of
human skin to 2 MED UVB compared to solar-simulated UV are
similar, suggesting that solar-simulated UV and UVB sources have
similar biologic responses in human skin in vivo. Thus, recent
concern that data obtained with UVB exposure may be misleading
when extrapolated to solar UV (Brown et al, 2000; Gasparro, 2000;
Gasparro and Brown, 2000) may be overstated, at least for human
skin in vivo.
Recent evidence indicates that acute UV exposure results in
rapid loss of type I and type III procollagen synthesis (Fisher et al,
2000). The TGF-b/Smad pathway is the major regulator of
synthesis of several components of the extracellular matrix,
including type I and type III collagen by skin ®broblasts. It is
reasonable to speculate that rapid UV impairment of the TGF-b/
Smad pathway, as described before, may contribute to reduced
procollagen synthesis. TGF-b2 and TbRII are reduced and Smad7
is induced within 8 h post UV. Type I and type III procollagen
synthesis is also reduced within 8 h post UV, consistent with the
possibility that reduced procollagen synthesis may be mediated, at
least in part, by the observed alterations in the TGF-b/Smad
pathway. The extent to which the acute effects of UV on TGF-b/
Smad signals described here are related to the long-term effects of
UV that result in photoaging and cancer remains to be determined.
We are indebted to Carolyn Petersen and Suzan Rehbine for the procurement of
tissue specimens, JingCheng Wang for technical assistance, Laura VanGoor for the
preparation of graphic material, and Ted Hamilton for statistical analysis.
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